Skip to main content
. 2011 Sep 16;4:361. doi: 10.1186/1756-0500-4-361

Table 3.

Subjective ratings of actual response performance1, 2, 3

ACTIVITY CAMB CYUN CGUA LAOS MYAN THAI VIET MEAN

'09 '10 '09 '10 '09 '10 '09 '10 '09 '10 '09 '10 '09 '10 '09 '10
Surveillance and Information Sharing

 Development/use of case definition 5 5 4 4 4 4 5 4 NR 5 4 4 5 4 4.5 4.3

 Active case finding/hospitals & clinics 5 4 5 4 5 4 3 4 NI 5 3 4 5 4 4.3 4.1

 Active case finding/communities 5 4 3 4 4 4 3 4 NR 5 3 4 3 4 3.5 4.1

 Active case finding/ports of entry 5 4 4 4 5 4 5 NI NR 5 4 4 4 4 4.5 4.2

 Electronic reporting of cases 5 4 5 5 5 4 NI 3 NR 4 4 4 3 4 4.4 4.0

 Hotline for reporting possible cases 5 5 4 5 3 4 3 4 5 5 3 4 4 4 3.9 4.4

 Initial testing in district/provincial lab NI 4 5 4 4 4 NI NI NI 4 3 NI 2 4 3.8 4.0

 Any other active surveillance activities 4 5 5 3 4 4 4 3 4 4 3 2 5 4 4.1 3.6

 Rapid Response Team mobilization 5 5 5 4 5 4 NR 4 4 4 3 5 5 4 4.5 4.3

 Communication w/cross-border site(s) 5 4 5 3 NI 4 NR 4 NR 4 3 NI 3 4 4.0 3.8

 Sharing info w/MBDS country 5 5 NI 3 NI 4 NR 4 NR 4 3 NI 4 4 4.0 4.0

 Sharing info w/MBDS Coordinator 5 5 4 4 NI 4 NR 4 NR 4 3 NI 4 4 4.0 4.2

MEAN 4.9 4.5 4.5 3.9 4.3 4.0 3.8 3.8 4.3 4.4 3.3 3.9 3.9 4.0 4.1 4.1

Disease Prevention and Control - Health Care Facilities

 Communications w/health workers 4 4 5 4 4 4 NR 4 NR 5 3 4 4 4 4.0 4.1

 Use hospital admission criteria 5 5 5 4 NI 4 NR 4 NR 5 4 5 4 4 4.5 4.4

 Preparation or use of isolation areas 5 4 5 5 4 4 NR 4 NR 5 4 5 5 4 4.6 4.4

 Use of PPE for health workers 5 5 5 5 4 4 NR 4 NR 4 4 5 4 4 4.4 4.4

 Use of antiviral drugs for treatment 5 5 5 4 4 4 NR 4 NR 5 4 5 4 4 4.4 4.4

 Use of antiviral drugs for prophylaxis 5 5 5 3 4 4 NR 3 3 4 3 5 4 4 4.0 4.0

 Focus on hospital infection control 4 4 5 4 5 4 NR 3 NR 5 3 5 5 4 4.4 4.1

 More preparation for medical surge 4 4 4 3 4 4 NR 3 NR 5 3 5 5 4 4.0 4.0

MEAN 4.6 4.5 4.9 4.0 4.1 4.0 -- 3.6 3.0 4.8 3.5 4.9 4.4 4.0 4.3 4.2

Disease Prevention and Control - Communities

 Containment measures (from WHO) 4 4 4 4 4 4 NI 4 NR 5 3 4 5 4 4.0 4.1

 Border control measures 4 4 NI 4 4 4 NR 3 NR 5 3 5 4 4 3.8 4.1

 Restrictions of travel NR NI NI 3 NI 3 NI 2 NI NI NI NI 4 4 4.0 3.0

 Restrictions of public gatherings 3 NI NI 4 NI 3 NI 2 NI 5 NI 2 4 4 3.5 3.3

 Closure of any schools 4 NI NI 4 NI 4 NI NI NR 5 3 3 3 4 3.3 4.0

MEAN 3.8 4.0 4.0 4.0 4.0 3.6 -- 2.8 -- 5.0 3.0 3.5 4.0 4.0 3.7 3.7

Risk Communications

 Spokesperson(s) identified 5 5 5 4 4 4 NR 4 5 4 4 4 5 4 4.7 4.1

 Public risk communications/targeted 5 4 5 3 4 4 NR 3 3 5 4 4 4 4 4.2 3.9

 Public risk communications/broad 4 4 4 4 3 3 NR 3 4 5 3 5 4 4 3.8 4.0

 Message consistency for public 4 5 5 4 4 4 NR 3 5 5 4 4 4 4 4.3 4.1

 Messages aimed to avoid public panic NR 4 3 4 4 4 NR 4 5 5 3 3 5 4 4.0 4.0

 Communications w/MBDS country NR 5 NI 3 NI 3 NR 4 3 5 3 NI 4 4 3.3 4.0

 Communications w/MBDS office 5 5 NI 4 NI 3 NR 4 4 4 NI NI 4 4 4.3 4.0

 Communications w/external partner 5 5 NI 3 NI 1 NR 4 4 3 NI NI 4 4 4.3 3.3

MEAN 4.7 4.6 4.4 3.6 4.0 3.3 -- 3.6 4.1 4.5 3.5 4.0 4.3 4.0 4.1 3.9

1. CAMB = Cambodia; CYUN = China Yunnan-Province; CGUA = China Guangxi Province; LAOS = Laos; MYAN = Myanmar; THAI = Thailand; VIET = Vietnam

2. Ratings of activity performance measured on a Likert Scale where 1 = very poor, 2 = poor, 3 = average, 4 = good and 5 = excellent

3. NI = not implemented; NR = no response